• Introduced
    Jan 21, 2026
  • Passed House
    Feb 09, 2026
  • Passed Senate
    Mar 02, 2026
  • Became Law
    Mar 10, 2026
HB 1099
South Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Last Action See all actions
executive • Mar 10, 2026: Signed by the Governor, H.J. 547

Summary

Comments on HB 1099

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Mar 10, 2026 | executive
    • Signed by the Governor, H.J. 547
  • Mar 05, 2026 | House
    • Delivered to the Governor, H.J. 520
  • Mar 04, 2026 | Senate
    • Signed by the President, S.J. 470
  • Mar 03, 2026 | House
    • Signed by the Speaker, H.J. 492
  • Mar 02, 2026 | Senate
    • Do Pass, Passed YEAS: 21, NAYS: 12, S.J. 429
  • Feb 26, 2026 | Senate
    • Remove from Consent Calendar, S.J. 412
  • Feb 25, 2026 | Senate
    • Health and Human Services Scheduled for hearing, S.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 6, NAYS: 0, S.J. 21
    • Health and Human Services Certified uncontested, placed on consent, S.J. 21
  • Feb 10, 2026 | Senate
    • First read in Senate and referred to Health and Human Services, S.J. 234
  • Feb 09, 2026 | House
    • Do Pass, Passed YEAS: 58, NAYS: 7, H.J. 265
  • Feb 05, 2026 | House
    • Health and Human Services Scheduled for hearing, H.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 13, NAYS: 0, H.J. 13
  • Jan 21, 2026 | House
    • First read in House and referred to Health and Human Services, H.J. 104
Documents
Looks like we don't have any documents available at this moment.